Log In
Print
BCIQ
Print
Print this Print this
 

ASP015K

  Manage Alerts
Collapse Summary General Information
Company Astellas Pharma Inc.
DescriptionOral JAK inhibitor
Molecular Target JAK kinase (JAK)
Mechanism of Action 
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today